Quoin Pharmaceuticals appoints Sally Lawlor as CFO

* Quoin Pharmaceuticals (NASDAQ:QNRX [https://seekingalpha.com/symbol/QNRX]) on Monday announced the appointment of Sally Lawlor as its new Chief Financial Officer as the company advances its lead product candidate, QRX003, through pivotal clinical studies and prepares for potential commercialization.
* In her most recent role at Sebela Pharmaceuticals, Lawlor managed financial reporting under U.S. GAAP and IFRS, oversaw global tax planning and compliance, as well as budgeting, forecasting, and external audits.
* Source: Press Release [https://seekingalpha.com/pr/20203572-quoin-pharmaceuticals-appoints-new-chief-financial-officer-to-support-commercialization]

MORE ON QUOIN PHARMACEUTICALS

* Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals [https://seekingalpha.com/symbol/QNRX/ratings/quant-ratings]
* Historical earnings data for Quoin Pharmaceuticals [https://seekingalpha.com/symbol/QNRX/earnings]
* Financial information for Quoin Pharmaceuticals [https://seekingalpha.com/symbol/QNRX/income-statement]